Re: "Inhibition of medullary thyroid carcinoma (MTC) cell proliferation and RET phosphorylation by tyrosine kinase inhibitors".
Plaza Menacho
Ivan
I
de Groot
Jan Willem
JW
Links
Thera
T
Plukker
John
J
Eggen
Bart J L
BJ
Hofstra
Robert
R
D001549:Benzamides; D018276:Carcinoma, Medullary / Q000188:drug therapy* / Q000473:pathology; D002455:Cell Division; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D006801:Humans; D000068877:Imatinib Mesylate; D015513:Oncogene Proteins / Q000378:metabolism*; D010766:Phosphorylation; D010879:Piperazines / Q000627:therapeutic use*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors / Q000378:metabolism; D051096:Proto-Oncogene Proteins c-ret; D011743:Pyrimidines / Q000627:therapeutic use*; D020794:Receptor Protein-Tyrosine Kinases / Q000378:metabolism*; D013964:Thyroid Neoplasms / Q000188:drug therapy* / Q000473:pathology
D001549:Benzamides; D004791:Enzyme Inhibitors; D015513:Oncogene Proteins; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate; D011505:Protein-Tyrosine Kinases; D051096:Proto-Oncogene Proteins c-ret; C099282:RET protein, human; D020794:Receptor Protein-Tyrosine Kinases